137 related articles for article (PubMed ID: 15845076)
21. Glutamate transporter expression and function in a striatal neuronal model of Huntington's disease.
Petr GT; Bakradze E; Frederick NM; Wang J; Armsen W; Aizenman E; Rosenberg PA
Neurochem Int; 2013 Jun; 62(7):973-81. PubMed ID: 23507328
[TBL] [Abstract][Full Text] [Related]
22. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington's disease.
Wang X; Wang H; Figueroa BE; Zhang WH; Huo C; Guan Y; Zhang Y; Bruey JM; Reed JC; Friedlander RM
J Neurosci; 2005 Dec; 25(50):11645-54. PubMed ID: 16354923
[TBL] [Abstract][Full Text] [Related]
23. Kinase signalling in Huntington's disease.
Bowles KR; Jones L
J Huntingtons Dis; 2014; 3(2):89-123. PubMed ID: 25062854
[TBL] [Abstract][Full Text] [Related]
24. Hip1 and Hippi participate in a novel cell death-signaling pathway.
Wanker EE
Dev Cell; 2002 Feb; 2(2):126-8. PubMed ID: 11832235
[TBL] [Abstract][Full Text] [Related]
25. A novel ex vivo Huntington's disease model for studying GABAergic neurons and cell grafts by laser microdissection.
André EM; Daviaud N; Sindji L; Cayon J; Perrot R; Montero-Menei CN
PLoS One; 2018; 13(3):e0193409. PubMed ID: 29505597
[TBL] [Abstract][Full Text] [Related]
26. Moving toward a gene therapy for Huntington's disease.
Glorioso JC; Cohen JB; Carlisle DL; Munoz-Sanjuan I; Friedlander RM
Gene Ther; 2015 Dec; 22(12):931-3. PubMed ID: 26633828
[No Abstract] [Full Text] [Related]
27. Model mammals. Sheep are helping scientists gain ground against Huntington's disease.
Yuhas D
Sci Am; 2012 Dec; 307(6):17. PubMed ID: 23230789
[No Abstract] [Full Text] [Related]
28. Huntington's disease: delayed hypersensitivity in vitro to human central nervous system antigens.
Barkley DS; Hardiwidjaja S; Menkes JH
Science; 1977 Jan; 195(4275):314-6. PubMed ID: 137525
[TBL] [Abstract][Full Text] [Related]
29. Drawing a Huntington's disease blueprint with NMR.
Gebel E
J Proteome Res; 2006 Mar; 5(3):469. PubMed ID: 16541533
[No Abstract] [Full Text] [Related]
30. Pathogenesis of Huntington's disease.
van Wolferen WJ; Teepen JL; Bruyn GW
Trends Neurosci; 1994 Mar; 17(3):107-8. PubMed ID: 7515525
[No Abstract] [Full Text] [Related]
31. Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements.
Pirhaji L; Milani P; Dalin S; Wassie BT; Dunn DE; Fenster RJ; Avila-Pacheco J; Greengard P; Clish CB; Heiman M; Lo DC; Fraenkel E
Nat Commun; 2017 Sep; 8(1):623. PubMed ID: 28931805
[TBL] [Abstract][Full Text] [Related]
32. 8-OHdG: its (limited) potential as a biomarker for Huntington's disease.
Killoran A; Biglan KM
Biomark Med; 2012 Dec; 6(6):777-80. PubMed ID: 23227841
[No Abstract] [Full Text] [Related]
33. Huntington's disease: From basic science to therapeutics.
Cepeda C; Tong XP
CNS Neurosci Ther; 2018 Apr; 24(4):247-249. PubMed ID: 29582586
[No Abstract] [Full Text] [Related]
34. Pentobarbitone anaesthesia in an animal model of huntington's disease.
Sanberg PR; Pisa M; Fibiger HC
Br J Anaesth; 1981 Apr; 53(4):442. PubMed ID: 6452890
[No Abstract] [Full Text] [Related]
35. [Treating early transient neuronal defects in a mouse model of Huntington's disease delays the signs of the disease in adulthood].
Wennagel D; Braz BY; Humbert S
Med Sci (Paris); 2023 Apr; 39(4):313-316. PubMed ID: 37094259
[No Abstract] [Full Text] [Related]
36. Trojan triplets: RNA-based pathomechanisms for muscle dysfunction in Huntington's disease.
Skov M; Dirksen RT
J Gen Physiol; 2017 Jan; 149(1):49-53. PubMed ID: 27940949
[No Abstract] [Full Text] [Related]
37. Correction to: Vildagliptin Attenuates Huntington's Disease Through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.
Sayed NH; Fathy N; Kortam MA; Rabie MA; Mohamed AF; Kamel AS
Neurotherapeutics; 2022 Mar; 19(2):686. PubMed ID: 35352287
[No Abstract] [Full Text] [Related]
38. Erratum: Valenza et al., "Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease".
J Neurosci; 2020 Sep; 40(38):7375. PubMed ID: 32873721
[No Abstract] [Full Text] [Related]
39. Correction: Sepers et al., "Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model".
J Neurosci; 2018 Aug; 38(33):7364. PubMed ID: 31329685
[TBL] [Abstract][Full Text] [Related]
40. Minocycline slows progress of Huntington's disease in mice.
Berger A
BMJ; 2000 Jul; 321(7253):70. PubMed ID: 10884247
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
